Johnson & Johnson Forecast, price target & analysts
Johnson & Johnson Target price 2026 - Analyst rating & recommendation
Johnson & Johnson Classifications & Recommendation
Johnson & Johnson Price Target
| Target Price | $285.60 |
| Price | $271.95 |
| Potential | 5.02% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Johnson & Johnson 2027 . The average Johnson & Johnson target price is $285.60. This is 5.02% higher than the current stock price. The highest price target is $320.25 17.76% , the lowest is $171.70 36.86% . | |
| A rating was issued by 31 analysts: 22 Analysts recommend Johnson & Johnson to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Johnson & Johnson stock has an average upside potential 2027 of 5.02% . Most analysts recommend the Johnson & Johnson stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
26 Analysts have issued a sales forecast Johnson & Johnson 2026 . The average Johnson & Johnson sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Johnson & Johnson EBITDA forecast 2026. The average Johnson & Johnson EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 Johnson & Johnson Analysts have issued a net profit forecast 2026. The average Johnson & Johnson net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
27 Analysts have issued a Johnson & Johnson forecast for earnings per share. The average Johnson & Johnson EPS is
This results in the following potential growth metrics and future valuations:
Johnson & Johnson...
Current Johnson & Johnson Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HSBC |
Buy
➜
Buy
|
Unchanged | Sep 10 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Sep 02 2026 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Aug 06 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Aug 03 2026 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Jul 17 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Jul 16 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jul 16 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
HSBC:
Buy
➜
Buy
|
Sep 10 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Sep 02 2026 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Aug 06 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Aug 03 2026 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Jul 17 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Jul 16 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jul 16 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
